Back Bay Life Science Advisors to Lead BioNetwork West Partnering Summit October 23-25

Back Bay Life Science Advisors (Back Bay) will again join biotech leaders at the BioNetwork West Partnering Summit this October. The summit brings together leaders from top life science organizations to discuss top trends in business development and highlight new technologies and innovations. For the third year, Back Bay will provide lead sponsorship for the event.Jonathan P. Gertler, MD, managing partner and CEO of Back Bay, will serve as event chairperson and will be joined by other members of Back Bay leadership, who will moderate key panel discussions around successful business development in the life sciences.Back Bay panels include:

Catching the Eye of Big Pharma

Moderated by Jonathan Gertler, MD

• Constructing a compelling pitch deck

• Keys to moving the dialogue forward

• Providing substantive evidence for opportunities

The Compelling Future of CNS & Neurodegenerative Diseases

Moderated by Michelle Hoffman, PhD, senior vice president, Back Bay

• What is the emerging science in the space?

• Where are the most interesting opportunities?

• What are the transactional challenges to overcome?

BioPharma Spinouts: When They Work & When They Don’t

Moderated by Chris Leo, PhD, senior vice president, Back Bay.

• Current increased spinout interest from large and small pharma

• What distinguishes deals that succeed from those that don’t?

• How to incentivize investors, licensors, and employees for buy-in?

BioNetwork West provides an intimate forum for life science executives in the biotechnology and pharmaceutical sector to come together to discuss top trends in business development and highlight new technologies and innovations.  The full agenda can be found here.